TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
Affinity DataIC50: 2nMAssay Description:Inhibition of recombinant human GIRK1/4 channelMore data for this Ligand-Target Pair
Ligand Info
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 6nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 8nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
Affinity DataIC50: 9nMAssay Description:Inhibition of recombinant human GIRK1/4 channelMore data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 9nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 9nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 11nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
Affinity DataIC50: 11nMAssay Description:Inhibition of recombinant human GIRK1/4 channelMore data for this Ligand-Target Pair
Ligand Info
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 13nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 13nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 14nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 15nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 15nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 16nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 17nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 19nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 23nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 24nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 25nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 25nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
Affinity DataIC50: 25nMAssay Description:Inhibition of recombinant human GIRK1/4 channelMore data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 26nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
Affinity DataIC50: 27nMAssay Description:Inhibition of recombinant human GIRK1/4 channelMore data for this Ligand-Target Pair
Ligand Info
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 28nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 28nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 4(Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 29nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 31nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair